Company: SCYX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0000950170-25-038044
Chunk: 218

Company: SCYNEXIS INC
Filing Date: 2025-03-12
Form: 10-K
Item: Item 8
Chunk 218
---
1.39

    Weighted average common shares outstanding – basic and diluted

    Basic

    48,513,073

    47,852,833

    Diluted

    48,513,073

    48,390,582

The accompanying notes are an integral part of the financial statements.

60

SCYNEXIS, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(in thousands, except share data)

    Shares ofCommonStock

    CommonStock

    AdditionalPaid-inCapital

    AccumulatedDeficit

    Total Stockholders’ Equity

    Balances as of December 31, 2022

    32,682,342

    $
    36

    $
    425,485

    $
    (422,288
    )
     
    $
    3,233

    Net income

    —

    —

    —

    67,041

    67,041

    Stock-based compensation expense

    —

    —

    2,624

    —

    2,624

    Common stock issued through employee stock purchase plan

    28,896

    —

    42

    —

    42

    Common stock issued, net of expenses

    4,150,400

    4

    —

    —

    4

    Common stock issued for vested restricted stock units

    346,161

    —

    18

    —

    18

    Balances as of December 31, 2023

    37,207,799

    $
    40

    $
    428,169

    $
    (355,247
    )
     
    $
    72,962

    Net loss

    —

    —

    —

    (21,288
    )

    (21,288
    )

    Stock-based compensation expense

    —

    —

    3,346

    —

    3,346

    Common stock issued through employee stock purchase plan

    45,593

    —

    56

    —

    56

    Common stock issued for vested restricted stock units

    720,599

    1

    —

    —

    1

    Balances as of December 31, 2024

    37,973,991

    $
    41

    $
    431,571